Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer
- 1 March 1995
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 6 (3) , 267-274
- https://doi.org/10.1093/oxfordjournals.annonc.a059157
Abstract
Background: Chemotherapy may relieve tumor-related symptoms, may improve quality of life and prolong survival in advanced gastrointestinal cancer. The extent of such improvements is unclear despite the extensive use of this treatment modality, and there are no studies concerning the economic costs involved. The aim of this study was to assess the economic cost of any gain achieved in the quantity and quality of life by chemotherapy. Patients and methods: Between January 1991 and May 1992, 61 patients with inoperable cancer (18 gastric, 22 pancreatic or biliary, and 21 colorectal) were randomized to either primary chemotherapy in addition to best supportive care or to best supportive care. Chemotherapy was allowed in the latter group if the supportive measures did not achieve palliation. All economic costs for medical care were prospectively recorded, and marginal cost-effectiveness analyses were performed. Results: More patients in the primary chemotherapy group (19/33, 58%) had improved/prolonged high quality of life (QoL-patient, minimum duration 4 months) than in the best supportive care group (8/28, 29%, pConclusions: The results of this study suggest that palliative chemotherapy is cost-effective in patientswith advanced gastric and colorectal cancer. Knowledge about survival and quality of life benefits is still limited in patients suffering from gastric and pancreatic-biliary cancer.Keywords
This publication has 24 references indexed in Scilit:
- Chemotherapy prolongs survival in inoperable pancreatic carcinomaBritish Journal of Surgery, 1994
- Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancerCancer, 1994
- Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.BMJ, 1993
- Biochemical modulation of 5-fluorouracil: A randomized comparison of sequential methotrexate, 5-fluorouracil and leucovorin versus sequential 5-fluorouracil and leucovorin in patients with advanced symptomatic colorectal cancerAnnals of Oncology, 1993
- Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial.Journal of Clinical Oncology, 1992
- Appropriate chemotherapy for palliating advanced cancer.BMJ, 1992
- General Condition of Asymptomatic Patients with Advanced Colorectal Cancer Receiving Palliative Chemotherapy: A longitudinal studyActa Oncologica, 1992
- Quality of life during cytostatic therapy for advanced symptomatic colorectal carcinoma: a randomized comparison of two regimensEuropean Journal of Cancer and Clinical Oncology, 1989
- Reporting results of cancer treatmentCancer, 1981
- Assessment of response to therapy in advanced breast cancerBritish Journal of Cancer, 1977